- Home
- PRTA vs NEWP Comparison
PRTA vs NEWP Comparison
Compare PRTA & NEWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRTA | NEWP |
|---|---|---|
| Founded | 2012 | 1972 |
| Country | US | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.3M | 575.1M |
| IPO Year | 2013 | 2006 |
Fundamental Metrics
Financial Performance| Metric | PRTA | NEWP |
|---|---|---|
| Price | $9.02 | $3.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $18.86 | $4.25 |
| AVG Volume (30 Days) | 364.7K | ★ 1.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.75 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $814,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,183.79 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.32 | $0.93 |
| 52 Week High | $16.67 | $4.70 |
Technical Indicators
Market Signals| Indicator | PRTA | NEWP |
|---|---|---|
| Relative Strength Index (RSI) | 47.97 | 50.72 |
| Support Level | $8.80 | $3.30 |
| Resistance Level | $9.23 | $3.98 |
| Average True Range (ATR) | 0.45 | 0.27 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 79.21 | 64.71 |
Price Performance
Historical ComparisonAbout PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About NEWP New Pacific Metals Corp.
New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.